DEF 14AThe Ballot
Neumora Therapeutics, Inc. files DEF 14A
Filed Apr 25, 2024 · 2y ago · Accession 0000950170-24-048287
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Neumora Therapeutics, Inc.
- Ticker
- NMRA
- CIK
- 1885522
- Form type
- DEF 14A
- Filing date
- Apr 25, 2024
- Report date
- Jun 13, 2024
- Document
- nmra_-_2024_proxy_-_def1.htm
- Size
- 983 KB